genedrive (LON:GDR) Trading Up 6.2% – What’s Next?

genedrive plc (LON:GDR)’s stock price was up 6.2% during trading on Thursday . The stock traded as high as GBX 1.20 and last traded at GBX 1.06. Approximately 24,689,480 shares were traded during trading, an increase of 288% from the average daily volume of 6,358,592 shares. The stock had previously closed at GBX 1.

genedrive Price Performance

The company has a market capitalization of £17.16 million, a price-to-earnings ratio of -1.35 and a beta of -0.04. The company has a quick ratio of 5.52, a current ratio of 0.99 and a debt-to-equity ratio of -120.48. The company has a 50 day simple moving average of GBX 0.99 and a 200 day simple moving average of GBX 0.97.

genedrive (LON:GDR) last posted its earnings results on Monday, March 30th. The company reported GBX (0.30) earnings per share (EPS) for the quarter. genedrive had a negative net margin of 500.75% and a negative return on equity of 1,044.57%. As a group, research analysts predict that genedrive plc will post 209.9999867 EPS for the current year.

About genedrive

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.